Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
63
AXP Quote, Financials, Valuation and Earnings
Last price:
$298.75
Seasonality move
:
5.47%
Day range:
$292.00 - $302.72
52-week range:
$177.81 - $307.82
Dividend yield:
0.9%
P/E ratio:
21.98x
P/S ratio:
3.33x
P/B ratio:
7.08x
Volume:
5.8M
Avg. volume:
2.5M
1-year change:
65.32%
Market cap:
$210.4B
Revenue:
$60.4B
EPS (TTM):
$13.59
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $43.6B | $36.2B | $43.1B | $52.6B | $60.4B | |
| Revenue Growth (YoY) | 8.23% | -16.95% | 19.06% | 21.82% | 14.85% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $13B | $9.4B | $11.5B | $12.7B | $13.3B | |
| Other Inc / (Exp) | $77M | $152M | $767M | -$302M | -$152M | |
| Operating Expenses | $12.9B | $9.3B | $11.5B | $12.6B | $13.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $8.4B | $4.3B | $10.7B | $9.6B | $10.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.7B | $1.2B | $2.6B | $2.1B | $2.1B | |
| Net Income to Company | $6.8B | $3.1B | $8.1B | $7.5B | $8.4B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.8B | $3.1B | $8.1B | $7.5B | $8.4B | |
| Basic EPS (Cont. Ops) | $8.00 | $3.77 | $10.04 | $9.86 | $11.23 | |
| Diluted EPS (Cont. Ops) | $7.99 | $3.77 | $10.02 | $9.85 | $11.21 | |
| Weighted Average Basic Share | $828M | $805M | $789M | $751M | $735M | |
| Weighted Average Diluted Share | $830M | $806M | $790M | $752M | $736M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $11.9B | $6.4B | $12B | $12.3B | $17.4B | |
| Revenue (Reported) | $43.6B | $36.2B | $43.1B | $52.6B | $60.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $11.9B | $6.4B | $12B | $12.3B | $17.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $8.8B | $11.1B | $13.5B | $15.4B | $16.6B | |
| Revenue Growth (YoY) | -19.77% | 25.55% | 22.03% | 13.86% | 8.16% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.2B | $2.9B | $3.2B | $3.3B | $3.5B | |
| Other Inc / (Exp) | $66M | $142M | -$47M | -- | -- | |
| Operating Expenses | $3.2B | $2.9B | $3.2B | $3.3B | $3.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.4B | $2.5B | $2.5B | $3.1B | $3.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $291M | $624M | $580M | $649M | $697M | |
| Net Income to Company | $1.1B | $1.8B | $1.9B | $2.5B | $2.5B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.1B | $1.8B | $1.9B | $2.5B | $2.5B | |
| Basic EPS (Cont. Ops) | $1.31 | $2.27 | $2.47 | $3.30 | $3.50 | |
| Diluted EPS (Cont. Ops) | $1.30 | $2.27 | $2.47 | $3.30 | $3.49 | |
| Weighted Average Basic Share | $804M | $786M | $748M | $732M | $708M | |
| Weighted Average Diluted Share | $805M | $787M | $749M | $733M | $709M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.8B | $2.8B | $3.3B | $4.9B | $5.3B | |
| Revenue (Reported) | $8.8B | $11.1B | $13.5B | $15.4B | $16.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.8B | $2.8B | $3.3B | $4.9B | $5.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $38.3B | $40.4B | $50.8B | $58.7B | $64.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $12.6B | $8.7B | $12.6B | $13.2B | $13.9B | |
| Other Inc / (Exp) | $88M | $810M | -$74M | -$234M | $531M | |
| Operating Expenses | $12.6B | $8.7B | $12.6B | $13.2B | $14.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.4B | $10.2B | $10B | $9.9B | $12.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1B | $2.5B | $2.4B | $1.9B | $2.8B | |
| Net Income to Company | $3.4B | $7.8B | $7.7B | $8B | $9.9B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.4B | $7.8B | $7.7B | $8B | $9.9B | |
| Basic EPS (Cont. Ops) | $4.05 | $9.58 | $9.96 | $10.68 | $13.63 | |
| Diluted EPS (Cont. Ops) | $4.03 | $9.57 | $9.95 | $10.66 | $13.59 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $6.9B | $11.6B | $11.9B | $16B | $20.8B | |
| Revenue (Reported) | $38.3B | $40.4B | $50.8B | $58.7B | $64.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $6.9B | $11.6B | $11.9B | $16B | $20.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $26.8B | $31B | $38.6B | $44.7B | $48.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9B | $8.3B | $9.4B | $9.9B | $10.5B | |
| Other Inc / (Exp) | $88M | $774M | -$68M | -- | $531M | |
| Operating Expenses | $9B | $8.3B | $9.4B | $9.9B | $11.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.4B | $8.4B | $7.7B | $8B | $10.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $741M | $2B | $1.8B | $1.6B | $2.2B | |
| Net Income to Company | $1.7B | $6.3B | $5.9B | $6.4B | $8B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.7B | $6.3B | $5.9B | $6.4B | $8B | |
| Basic EPS (Cont. Ops) | $2.01 | $7.82 | $7.77 | $8.60 | $11.00 | |
| Diluted EPS (Cont. Ops) | $2.00 | $7.81 | $7.77 | $8.59 | $10.97 | |
| Weighted Average Basic Share | $2.4B | $2.4B | $2.3B | $2.2B | $2.1B | |
| Weighted Average Diluted Share | $2.4B | $2.4B | $2.3B | $2.2B | $2.1B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $4.1B | $9.4B | $9.3B | $12.9B | $16.4B | |
| Revenue (Reported) | $26.8B | $31B | $38.6B | $44.7B | $48.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $4.1B | $9.4B | $9.3B | $12.9B | $16.4B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $24.3B | $32.8B | $21.5B | $33.5B | $46.5B | |
| Short Term Investments | $8.3B | $21.6B | $2.5B | $4.5B | $1.8B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $32.7B | $54.5B | $24.5B | $38.4B | $48.3B | |
| Property Plant And Equipment | $4.8B | $5B | $5B | $5.2B | $5.1B | |
| Long-Term Investments | $8.4B | $21.6B | $2.6B | $4.6B | $2.2B | |
| Goodwill | $3.3B | $3.9B | $3.8B | $3.8B | $3.9B | |
| Other Intangibles | $267M | $265M | $201M | $146M | $98M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $198.3B | $191.4B | $188.5B | $228.4B | $261.1B | |
| Accounts Payable | $12.7B | $9.4B | $10.6B | $12.1B | $13.1B | |
| Accrued Expenses | $1.8B | $1.4B | $1.8B | $2.1B | $2.1B | |
| Current Portion Of Long-Term Debt | $3.4B | $1.9B | $2.2B | $1.3B | $1.3B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $22.1B | $13.6B | $16.2B | $17.3B | $17.7B | |
| Long-Term Debt | $57.8B | $42.9B | $38.7B | $42.6B | $47.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $175.3B | $168.4B | $166.4B | $203.6B | $233.1B | |
| Common Stock | $163M | $161M | $153M | $149M | $145M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $23.1B | $23B | $22.2B | $24.7B | $28.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $23.1B | $23B | $22.2B | $24.7B | $28.1B | |
| Total Liabilities and Equity | $198.3B | $191.4B | $188.5B | $228.4B | $261.1B | |
| Cash and Short Terms | $32.6B | $54.4B | $24B | $38.1B | $48.3B | |
| Total Debt | $64.3B | $44.8B | $40.9B | $43.9B | $49.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $32.7B | $27.5B | $30B | $43.8B | $47.8B | |
| Short Term Investments | $14.3B | $8.5B | $2.3B | $2.8B | $867M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $47.5B | $36.4B | $32.6B | $46.6B | $48.7B | |
| Property Plant And Equipment | $4.8B | $5B | $5.1B | $5.1B | $5.3B | |
| Long-Term Investments | $22.4B | $9.6B | $4.5B | $3.2B | $1.3B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $187.3B | $184.3B | $214.9B | $250.6B | $271B | |
| Accounts Payable | $8.2B | $9.6B | $11B | $13.2B | $13.2B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.7B | $2.3B | $1.5B | $1.6B | $1.5B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $9.9B | $11.9B | $12.5B | $14.8B | $14.6B | |
| Long-Term Debt | $44.8B | $34.5B | $42.4B | $46.4B | $53.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $165.4B | $159.8B | $191B | $223.3B | $241.3B | |
| Common Stock | $161M | $156M | $150M | $146M | $141M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | $734M | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $21.9B | $24.4B | $23.9B | $27.3B | $29.7B | |
| Total Liabilities and Equity | $187.3B | $184.3B | $214.9B | $250.6B | $271B | |
| Cash and Short Terms | $47.1B | $36B | $32.3B | $46.6B | $48.7B | |
| Total Debt | $46.5B | $36.7B | $43.9B | $48.1B | $55B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.8B | $3.1B | $8.1B | $7.5B | $8.4B | |
| Depreciation & Amoritzation | $1.2B | $1.5B | $1.7B | $1.6B | $1.7B | |
| Stock-Based Compensation | $283M | $249M | $330M | $375M | $450M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.6B | $5.6B | $14.6B | $21.1B | $18.6B | |
| Capital Expenditures | $1.6B | $1.5B | $1.6B | $1.9B | $1.6B | |
| Cash Acquisitions | -$352M | -$597M | $1M | -$15M | -$64M | |
| Cash From Investing | -$16.7B | $11.6B | -$10.5B | -$33.7B | -$24.4B | |
| Dividends Paid (Ex Special Dividend) | -$1.4B | -$1.5B | -$1.4B | -$1.6B | -$1.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $12.7B | $69M | $7.8B | $23.2B | $15.7B | |
| Long-Term Debt Repaid | -$13.9B | -$15.6B | -$11.7B | -$18.9B | -$10.7B | |
| Repurchase of Common Stock | -$4.7B | -$1B | -$9.3B | -$3.5B | -$3.7B | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$519M | -$9.1B | -$14.9B | $24.5B | $18.4B | |
| Beginning Cash (CF) | $27.8B | $24.4B | $33B | $22B | $33.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.6B | $8.2B | -$10.8B | $11.9B | $12.5B | |
| Ending Cash (CF) | $24.4B | $33B | $22B | $33.9B | $46.6B | |
| Levered Free Cash Flow | $12B | $4.1B | $13.1B | $19.2B | $17B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1B | $1.8B | $1.9B | $2.5B | $2.5B | |
| Depreciation & Amoritzation | $404M | $442M | $413M | $429M | $437M | |
| Stock-Based Compensation | $66M | $73M | $84M | $93M | $113M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.2B | $4.2B | $4.5B | $8.2B | -$1.8B | |
| Capital Expenditures | $353M | $430M | $443M | $401M | $455M | |
| Cash Acquisitions | -- | -- | -- | -- | -$80M | |
| Cash From Investing | -$5B | -$1.2B | -$7.5B | -$6.9B | -$3.5B | |
| Dividends Paid (Ex Special Dividend) | -$363M | -$366M | -$407M | -$459M | -$516M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $20M | $6B | $5B | $4.2B | |
| Long-Term Debt Repaid | -$4B | -$2.8B | -$4B | -$5.4B | -$3.2B | |
| Repurchase of Common Stock | -$1M | -$4.1B | -$601M | -$1.4B | -$1.9B | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$3.6B | -$5.9B | $7.7B | -$314M | $350M | |
| Beginning Cash (CF) | $42.1B | $30.8B | $26.3B | $43B | $52.9B | |
| Foreign Exchange Rate Adjustment | -$97M | $46M | $205M | -$51M | $7M | |
| Additions / Reductions | -$6.4B | -$2.9B | $4.7B | $1B | -$5B | |
| Ending Cash (CF) | $35.6B | $27.9B | $31.2B | $43.9B | $47.9B | |
| Levered Free Cash Flow | $1.8B | $3.7B | $4.1B | $7.8B | -$2.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.4B | $7.8B | $7.7B | $8B | $9.9B | |
| Depreciation & Amoritzation | $1.4B | $1.7B | $1.6B | $1.6B | $1.7B | |
| Stock-Based Compensation | $241M | $330M | $356M | $434M | $502M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.3B | $13.1B | $17.7B | $20.2B | $15B | |
| Capital Expenditures | $1.5B | $1.5B | $1.8B | $1.7B | $1.8B | |
| Cash Acquisitions | -$82M | $1M | -$15M | -$64M | $504M | |
| Cash From Investing | $11.7B | -$4.8B | -$34.2B | -$27B | -$20.3B | |
| Dividends Paid (Ex Special Dividend) | -$1.5B | -$1.5B | -$1.5B | -$1.7B | -$1.9B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $107M | $28.5B | $15.6B | $15B | |
| Long-Term Debt Repaid | -$14.3B | -$10.1B | -$20B | -$11.6B | -$8.8B | |
| Repurchase of Common Stock | -$2.2B | -$5.5B | -$6.6B | -$3.4B | -$5.9B | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$7B | -$16B | $19.3B | $19.9B | $9.3B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $10.1B | -$7.6B | $2.7B | $13.1B | $4B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $3.8B | $11.6B | $15.8B | $18.6B | $13.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.7B | $6.3B | $5.9B | $6.4B | $8B | |
| Depreciation & Amoritzation | $1.1B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Stock-Based Compensation | $175M | $256M | $282M | $341M | $393M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.1B | $9.6B | $12.6B | $11.8B | $8.3B | |
| Capital Expenditures | $1B | $1.1B | $1.3B | $1.1B | $1.4B | |
| Cash Acquisitions | -- | $1M | -$15M | -$64M | $504M | |
| Cash From Investing | $17.2B | $793M | -$22.9B | -$16.3B | -$12.2B | |
| Dividends Paid (Ex Special Dividend) | -$1.1B | -$1.1B | -$1.2B | -$1.3B | -$1.5B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $38M | $20.7B | $13.1B | $12.5B | |
| Long-Term Debt Repaid | -$13.7B | -$8.2B | -$16.5B | -$9.3B | -$7.4B | |
| Repurchase of Common Stock | -$1B | -$5.5B | -$2.9B | -$2.7B | -$5B | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$8.4B | -$15.3B | $18.9B | $14.3B | $5.2B | |
| Beginning Cash (CF) | $105.2B | $104B | $76B | $117.7B | $153.7B | |
| Foreign Exchange Rate Adjustment | $283M | -$181M | $489M | $156M | $1M | |
| Additions / Reductions | $10.9B | -$4.9B | $8.7B | $9.8B | $1.3B | |
| Ending Cash (CF) | $116.3B | $99B | $85.1B | $127.7B | $155B | |
| Levered Free Cash Flow | $1B | $8.6B | $11.3B | $10.7B | $6.9B | |
Get AXP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AXP
Sector
P/E ratio
21.98x
11.99x
PEG ratio
0.80x
0.36x
P/B ratio
7.08x
1.05x
Price / LTM sales
3.33x
2.55x
Growth Metrics
AXP
Sector
Revenue growth
8.16%
6.08%
Earnings growth
5.76%
6.45%
Revenue (5-year growth)
8.41%
5.85%
Earnings forecast
$3.29
$0.56
Profitability
AXP
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
12.39%
5.27%
Return on assets
3.74%
0.98%
Return on equity
34.49%
9.43%
Earnings Date
Last Earnings Date
Oct
18
Next Earnings Date
Jan
24
Estimated Next Earnings Date
Jan
17
Balance Sheet
AXP
Sector
Total cash
$48.7B
$615.3M
Short term investments
$1.8B
$408.4M
Total assets
$261.1B
$4.5B
Long term debt
$55B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
